Previous close | 39.33 |
Open | 39.30 |
Bid | 39.31 x 37000 |
Ask | 39.38 x 43000 |
Day's range | 38.72 - 39.60 |
52-week range | 36.90 - 59.70 |
Volume | |
Avg. volume | 5,003 |
Market cap | 79.645B |
Beta (5Y monthly) | 0.43 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.23 (5.69%) |
Ex-dividend date | 05 Jul 2024 |
1y target est | N/A |
PRINCETON, N.J., June 21, 2024--Bristol Myers Squibb Announces U.S. FDA Accelerated Approval of KRAZATI® (adagrasib) in Combination with Cetuximab for Adult Patients with...
PRINCETON, N.J., June 21, 2024--European Medicines Agency Validates Bristol Myers Squibb's Application for Subcutaneous Nivolumab
PRINCETON, N.J., June 20, 2024--Bristol Myers Squibb to Report Results for Second Quarter 2024 on July 26, 2024